LFVN Lifevantage Corp

Price (delayed)

$6.24

Market cap

$80.3M

P/E Ratio

27.13

Dividend/share

$0.14

EPS

$0.23

Enterprise value

$76.75M

LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced ...

Highlights
The net income has grown by 16% from the previous quarter
LFVN's EPS is up by 15% QoQ
The price to earnings (P/E) is 37% more than the 5-year quarterly average of 19.6
The company's equity fell by 14% YoY and by 7% QoQ

Key stats

What are the main financial stats of LFVN
Market
Shares outstanding
12.87M
Market cap
$80.3M
Enterprise value
$76.75M
Valuations
Price to earnings (P/E)
27.13
Price to book (P/B)
2.91
Price to sales (P/S)
0.37
EV/EBIT
20.35
EV/EBITDA
8.54
EV/Sales
0.36
Earnings
Revenue
$210.95M
EBIT
$3.77M
EBITDA
$8.98M
Free cash flow
$10.56M
Per share
EPS
$0.23
Free cash flow per share
$0.84
Book value per share
$2.15
Revenue per share
$16.73
TBVPS
$4.94
Balance sheet
Total assets
$62.68M
Total liabilities
$35.38M
Debt
$13.78M
Equity
$27.31M
Working capital
$15.64M
Liquidity
Debt to equity
0.5
Current ratio
1.68
Quick ratio
0.85
Net debt/EBITDA
-0.4
Margins
EBITDA margin
4.3%
Gross margin
79.6%
Net margin
1.4%
Operating margin
1.7%
Efficiency
Return on assets
4.5%
Return on equity
9.5%
Return on invested capital
10.1%
Return on capital employed
9.5%
Return on sales
1.8%
Dividend
Dividend yield
2.24%
DPS
$0.14
Payout ratio
60.9%

LFVN stock price

How has the Lifevantage stock price performed over time
Intraday
1.13%
1 week
-6.31%
1 month
-0.48%
1 year
85.31%
YTD
4%
QTD
3.14%

Financial performance

How have Lifevantage's revenue and profit performed over time
Revenue
$210.95M
Gross profit
$168.02M
Operating income
$3.69M
Net income
$2.96M
Gross margin
79.6%
Net margin
1.4%
The net margin has grown by 17% from the previous quarter
The net income has grown by 16% from the previous quarter
LFVN's operating income is up by 9% year-on-year
The company's operating margin rose by 6% YoY

Growth

What is Lifevantage's growth rate over time

Valuation

What is Lifevantage stock price valuation
P/E
27.13
P/B
2.91
P/S
0.37
EV/EBIT
20.35
EV/EBITDA
8.54
EV/Sales
0.36
The price to earnings (P/E) is 37% more than the 5-year quarterly average of 19.6
LFVN's EPS is up by 15% QoQ
The price to book (P/B) is 37% higher than the last 4 quarters average of 2.1 but 18% lower than the 5-year quarterly average of 3.5
The company's equity fell by 14% YoY and by 7% QoQ
The P/S is 26% less than the 5-year quarterly average of 0.5 but 23% more than the last 4 quarters average of 0.3
The revenue has increased by 2.2% year-on-year

Efficiency

How efficient is Lifevantage business performance
LFVN's return on equity is up by 20% since the previous quarter
The company's return on assets rose by 18% QoQ
The return on invested capital is up by 3.1% since the previous quarter

Dividends

What is LFVN's dividend history
DPS
$0.14
Dividend yield
2.24%
Payout ratio
60.9%
Recent dividends

Financial health

How did Lifevantage financials performed over time
Lifevantage's total assets is 77% more than its total liabilities
The current ratio has contracted by 12% YoY
Lifevantage's total assets has decreased by 8% YoY and by 6% from the previous quarter
The debt is 50% less than the equity
The company's equity fell by 14% YoY and by 7% QoQ
The company's debt to equity rose by 11% YoY and by 4.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.